Shehnaaz Suliman, chief executive of Dallas-based ReCode Therapeutics, is among 71 female biotech CEOs authoring a letter to elected officials and lawmakers that condemns the U.S. Supreme Court decision overturning Roe vs. Wade.
The letter has since been signed by dozens more, marking a collective message from women in biotech leadership across the country.
“We join the resounding millions in chorus to express our profound dismay and disappointment at the United States Supreme Court’s decisions to strike down and ignore our fundamental rights as women to make personal reproductive health choices and for clinicians to practice evidence-based medicine without fear of reprisal,” the letter read.
